Our study team is working on starting two potential clinical trials at Oak Hill during the 2017-2018 school year. Enlyte, a supplement based on folate, and CM-AT, a pancreatic enzyme that naturally occurs in the body, have shown promising behavioral and social benefits in children with autism in clinical practice and preliminary research. Based on our 2016 sulforaphane study, we are hoping to use urinary metabolomics to understand how these supplements may work in the body and what biomedical profiles of children may benefit from supplementing with these.
Keep an eye out for more information from us or consider joining these studies! If you have any questions or are interested in joining, you may contact the study coordinator Tracy Warren at email@example.com or (415) 476-8803.